Baxter International Aktie
WKN: 853815 / ISIN: US0718131099
31.08.2022 15:27:20
|
Baxter: FDA Approves New Novum IQ Syringe Infusion Pump With Dose IQ Safety Software
(RTTNews) - Baxter International Inc. (BAX) announced the FDA 510(k) clearance of its new Novum IQ syringe infusion pump with Dose IQ Safety Software. The company noted that its Novum IQ SYR has the capability to fully integrate with hospital electronic medical records through Baxter's IQ Enterprise Connectivity Suite.
The Novum IQ SYR features the company's Dose IQ Safety Software, a web-based, customizable drug library and dose error reduction system. The company said its Novum IQ SYR was designed to meet rigorous FDA guidance for infusion devices, including cybersecurity.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Baxter International Inc.mehr Nachrichten
Analysen zu Baxter International Inc.mehr Analysen
Aktien in diesem Artikel
Baxter International Inc. | 27,82 | 8,57% |
|